These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 3063971

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Beneficial mechanisms of action of a prostacyclin enhancing agent in splanchnic artery occlusion shock.
    Aoki N, Siegfried M, Tsao P, Lento P, Lefer AM.
    Res Commun Chem Pathol Pharmacol; 1988 Jun; 60(3):275-89. PubMed ID: 3175328
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mechanisms of action of PGE1 in hemorrhagic shock in rats.
    Bitterman H, Stahl GL, Terashita Z, Lefer AM.
    Ann Emerg Med; 1988 May; 17(5):457-62. PubMed ID: 3364825
    [Abstract] [Full Text] [Related]

  • 6. Beneficial actions of antagonism of peptide leukotrienes in hemorrhagic shock.
    Bitterman H, Smith BA, Lefer AM.
    Circ Shock; 1988 Mar; 24(3):159-68. PubMed ID: 3383353
    [Abstract] [Full Text] [Related]

  • 7. Salutary consequences of blockade of platelet activating factor in hemorrhagic shock.
    Stahl GL, Bitterman H, Terashita Z, Lefer AM.
    Eur J Pharmacol; 1988 May 10; 149(3):233-40. PubMed ID: 3409951
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Novel beneficial mechanisms of defibrotide, a prostacyclin enhancing agent in splanchnic artery occlusion and reperfusion in rats.
    Ma XL, Porta R, Pescador R, Lefer AM.
    Methods Find Exp Clin Pharmacol; 1991 Dec 10; 13(10):667-74. PubMed ID: 1663194
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Potentiation of the protective effects of a converting enzyme inhibitor and a thromboxane synthetase inhibitor in hemorrhagic shock.
    Bitterman H, Phillips GR, Dragon G, Lefer AM.
    J Pharmacol Exp Ther; 1987 Jul 10; 242(1):8-14. PubMed ID: 3039116
    [Abstract] [Full Text] [Related]

  • 12. Effects of defibrotide on prostacyclin release from isolated rabbit kidneys and protection from post-ischemic acute renal failure in vivo.
    Berti F, Rossoni G, Bianchi G, Alberico P, Tettamanti R, Calvani AB, Mantovani M, Prino G.
    Eicosanoids; 1991 Jul 10; 4(4):209-15. PubMed ID: 1789997
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Anti-shock properties of the prostacyclin analog, iloprost, in traumatic shock.
    Levitt MA, Lefer AM.
    Prostaglandins Leukot Med; 1986 Dec 10; 25(2-3):175-85. PubMed ID: 2434958
    [Abstract] [Full Text] [Related]

  • 18. Salutary effects of nitrendipine, a new calcium entry blocker, in hemorrhagic shock.
    Hock CE, Su JY, Lefer AM.
    Eur J Pharmacol; 1984 Jan 13; 97(1-2):37-46. PubMed ID: 6698110
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.